205 related articles for article (PubMed ID: 25967993)
1. Biomarkers of necrotising soft tissue infections: aspects of the innate immune response and effects of hyperbaric oxygenation-the protocol of the prospective cohort BIONEC study.
Hansen MB; Simonsen U; Garred P; Hyldegaard O
BMJ Open; 2015 May; 5(5):e006995. PubMed ID: 25967993
[TBL] [Abstract][Full Text] [Related]
2. Biomarkers of Necrotising Soft Tissue Infections Aspects of the Innate Immune Response.
Hansen MB
Dan Med J; 2017 Jul; 64(7):. PubMed ID: 28673381
[TBL] [Abstract][Full Text] [Related]
3. How biomarkers reflect the prognosis and treatment of necrotising soft tissue infections and the effects of hyperbaric oxygen therapy: the protocol of the prospective cohort PROTREAT study conducted at a tertiary hospital in Copenhagen, Denmark.
Polzik P; Johansson PI; Hyldegaard O
BMJ Open; 2017 Oct; 7(10):e017805. PubMed ID: 28982834
[TBL] [Abstract][Full Text] [Related]
4. Pentraxin-3 as a marker of disease severity and risk of death in patients with necrotizing soft tissue infections: a nationwide, prospective, observational study.
Hansen MB; Rasmussen LS; Garred P; Bidstrup D; Madsen MB; Hyldegaard O
Crit Care; 2016 Feb; 20():40. PubMed ID: 26880104
[TBL] [Abstract][Full Text] [Related]
5. Not just full of hot air: hyperbaric oxygen therapy increases survival in cases of necrotizing soft tissue infections.
Shaw JJ; Psoinos C; Emhoff TA; Shah SA; Santry HP
Surg Infect (Larchmt); 2014 Jun; 15(3):328-35. PubMed ID: 24786980
[TBL] [Abstract][Full Text] [Related]
6. Association between cytokine response, the LRINEC score and outcome in patients with necrotising soft tissue infection: a multicentre, prospective study.
Hansen MB; Rasmussen LS; Svensson M; Chakrakodi B; Bruun T; Madsen MB; Perner A; Garred P; Hyldegaard O; Norrby-Teglund A;
Sci Rep; 2017 Feb; 7():42179. PubMed ID: 28176831
[TBL] [Abstract][Full Text] [Related]
7. Complement Activation Is Associated With Mortality in Patients With Necrotizing Soft-Tissue Infections-A Prospective Observational Study.
Kristensen MK; Hansen MB; Madsen MB; Hansen CB; Pilely K; Hyldegaard O; Garred P
Front Immunol; 2020; 11():17. PubMed ID: 32082310
[No Abstract] [Full Text] [Related]
8. [Hyperbaric oxygen therapy for necrotizing soft tissue infections: contra].
Willy C; Rieger H; Vogt D
Chirurg; 2012 Nov; 83(11):960-72. PubMed ID: 23138865
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors in necrotizing soft-tissue infections (NSTI): A cohort study.
Hua C; Sbidian E; Hemery F; Decousser JW; Bosc R; Amathieu R; Rahmouni A; Wolkenstein P; Valeyrie-Allanore L; Brun-Buisson C; de Prost N; Chosidow O
J Am Acad Dermatol; 2015 Dec; 73(6):1006-12.e8. PubMed ID: 26412163
[TBL] [Abstract][Full Text] [Related]
10. Contemporary national outcomes of hyperbaric oxygen therapy in necrotizing soft tissue infections.
Toppen W; Cho NY; Sareh S; Kjellberg A; Medak A; Benharash P; Lindholm P
PLoS One; 2024; 19(3):e0300738. PubMed ID: 38512943
[TBL] [Abstract][Full Text] [Related]
11. Scarce evidence of efficacy of hyperbaric oxygen therapy in necrotizing soft tissue infection: a systematic review.
Faunø Thrane J; Ovesen T
Infect Dis (Lond); 2019 Jul; 51(7):485-492. PubMed ID: 30985236
[No Abstract] [Full Text] [Related]
12. Factors associated with mortality in patients with extremity necrotizing soft-tissue infections: a single academic center experience.
Nagira K; Ogoshi T; Akahori K; Enokida S; Enokida M; Ueda T; Homma M; Nagashima H
Langenbecks Arch Surg; 2023 May; 408(1):189. PubMed ID: 37166568
[TBL] [Abstract][Full Text] [Related]
13. Adjunctive hyperbaric oxygen treatment for necrotising soft-tissue infections: A systematic review and meta-analysis.
Hedetoft M; Bennett MH; Hyldegaard O
Diving Hyperb Med; 2021 Mar; 51(1):34-43. PubMed ID: 33761539
[TBL] [Abstract][Full Text] [Related]
14. Are we getting necrotizing soft tissue infections right? A 10-year review.
Proud D; Bruscino Raiola F; Holden D; Paul E; Capstick R; Khoo A
ANZ J Surg; 2014 Jun; 84(6):468-72. PubMed ID: 24164901
[TBL] [Abstract][Full Text] [Related]
15. Immunocompromised status in patients with necrotizing soft-tissue infection.
Keung EZ; Liu X; Nuzhad A; Adams C; Ashley SW; Askari R
JAMA Surg; 2013 May; 148(5):419-26. PubMed ID: 23677405
[TBL] [Abstract][Full Text] [Related]
16. Hyperbaric oxygen treatment is associated with a decrease in cytokine levels in patients with necrotizing soft-tissue infection.
Hedetoft M; Garred P; Madsen MB; Hyldegaard O
Physiol Rep; 2021 Mar; 9(6):e14757. PubMed ID: 33719215
[TBL] [Abstract][Full Text] [Related]
17. Equipoise: an important ethical consideration when contemplating participation in a randomised controlled trial of hyperbaric oxygen treatment in necrotising soft tissue infections.
Devaney B
Diving Hyperb Med; 2024 Mar; 54(1):57-60. PubMed ID: 38507910
[TBL] [Abstract][Full Text] [Related]
18. Hyperbaric oxygen does not improve outcome in patients with necrotizing soft tissue infection.
George ME; Rueth NM; Skarda DE; Chipman JG; Quickel RR; Beilman GJ
Surg Infect (Larchmt); 2009 Feb; 10(1):21-8. PubMed ID: 18991520
[TBL] [Abstract][Full Text] [Related]
19. Necrotising soft tissue infections: the effect of hyperbaric oxygen on mortality.
Devaney B; Frawley G; Frawley L; Pilcher DV
Anaesth Intensive Care; 2015 Nov; 43(6):685-92. PubMed ID: 26603791
[TBL] [Abstract][Full Text] [Related]
20. Investigating the Effects of Hyperbaric Oxygen Treatment in Necrotizing Soft Tissue Infection With Transcriptomics and Machine Learning (the HBOmic Study): Protocol for a Prospective Cohort Study With Data Validation.
Vinkel J; Rib L; Buil A; Hedetoft M; Hyldegaard O
JMIR Res Protoc; 2022 Nov; 11(11):e39252. PubMed ID: 36427229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
